Mutated and non-mutated TP53 as targets in the treatment of leukaemia (original) (raw)
hernan concha2008, British Journal of Haematology
visibility
…
description
9 pages
link
1 file
Sign up for access to the world's latest research.
checkGet notified about relevant papers
checkSave papers to use in your research
checkJoin the discussion with peers
checkTrack your impact
Related papers
British Journal of Haematology, 2014
TP53 Codon 72 Polymorphism and Risk of Acute Leukemia
Asian Pacific Journal of Cancer Prevention, 2012
p53 Gene Replacement for Cancer&Interactions with DNA Damaging Agents
Acta Oncologica, 2001
EXPRESSION OF p53 IN HUMAN BREAST CANCER
Biological Markers in Fundamental and Clinical Medicine (collection of abstracts), 2017
P53 in Breast Cancer: Mutation and Countermeasures
Frontiers in Bioscience, 2007
Recurrent TP53 missense mutation in cancer patients of Arab descent
Familial Cancer, 2016
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia
Leukemia, 2012
P53: A Molecular Marker for the Detection of Cancer
Expert Opinion on Medical Diagnostics, 2008
Wildtype p53-specific Antibody and T-Cell Responses in Cancer Patients
Journal of Immunotherapy, 2011
Transcription of genes of p53-dependent apoptosis in acute leukaemia
International Journal of Molecular Medicine, 1998
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.
Related papers
Translational approaches targeting the p53 pathway for anti-cancer therapy
British Journal of Pharmacology, 2012
P53-FAMILY Proteins and Their Regulators: Hubs and Spokes in Tumor Suppression
Cell Death & Differentiation, 2010
P53 at the Crossroads Between Cancer and Neurodegeneration
Free Radical Biology and Medicine, 2012
P53 is Essential for Chemotherapy-Induced Hair Loss
2000
Blood Cancer Journal, 2015
Mutations in p53, p53 protein overexpression and breast cancer survival
Carolina Digital Repository (University of North Carolina at Chapel Hill), 2009
On p53 revival using system oriented drug dosage design
Journal of Theoretical Biology, 2017
On the shoulders of giants: p63, p73 and the rise of p53
Trends in Genetics, 2002
Repair or perish – the role of p53 protein in a cell’s life
Nowotwory. Journal of Oncology, 2019
TP53 mutation analysis in chronic lymphocytic leukemia: comparison of different detection methods
Tumor Biology, 2014
International Journal of Laboratory Hematology, 2019
2009
Research Square (Research Square), 2019
Complex analysis of the p53 tumor suppressor in lung carcinoma
Oncology Reports, 2015
Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes
Oncogene, 2004
2023
Association between TP53 gene ARG72PRO polymorphism and chromosome aberrations in human cancers
Molecular Carcinogenesis, 2010
The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30
Familial Cancer, 2009
The Journal of Thoracic and Cardiovascular Surgery, 2008
Oncogene, 2002
The TP53 tumor suppressor and autophagy in malignant lymphoma
Autophagy, 2012
The Promyelocytic Leukemia Protein Protects p53 from Mdm2-mediated Inhibition and Degradation
Journal of Biological Chemistry, 2003
Oncotarget, 2017
Stage-specific sensitivity to p53 restoration during lung cancer progression
Nature, 2010
International Journal of Oncology, 1993
Related topics
HematologyCancerBritishBiologyTreatmentCell CycleMembrane ProteinsApoptosisMedicineAcute Myeloid LeukemiaMutationCell DeathAntineoplastic AgentsFuransVidarabineDrug synergismChromosome aberrationsDaunorubicinCardiovascular medicine and haem...